Drug profile · INN
daclatasvir
DAKLINZA
daclatasvir (DAKLINZA) is an FDA-listed pharmaceutical active ingredient.
EMA: unknown Antiinfectives for systemic use (J05) J05AP07
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — daclatasvir
- Class
- Antiinfectives for systemic use (J05)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
daclatasvir (DAKLINZA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN daclatasvir
Brand DAKLINZA
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AP07
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is daclatasvir?
daclatasvir (DAKLINZA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for daclatasvir?
DAKLINZA is a marketed brand name for daclatasvir. Check FDA Drugs@FDA for the current US label holder and prescribing information.